UBS Group’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-113,817
| Closed | -$36K | – | 7362 |
|
|
2018
Q1 | $36K | Buy |
113,817
+48,941
| +75% | +$15.5K | ﹤0.01% | 5110 |
|
|
2017
Q4 | $107K | Sell |
64,876
-16,306
| -20% | -$26.9K | ﹤0.01% | 4377 |
|
|
2017
Q3 | $117K | Buy |
81,182
+22,730
| +39% | +$32.8K | ﹤0.01% | 4360 |
|
|
2017
Q2 | $95K | Buy |
58,452
+11,453
| +24% | +$18.6K | ﹤0.01% | 4324 |
|
|
2017
Q1 | $160K | Buy |
46,999
+4,238
| +10% | +$14.4K | ﹤0.01% | 3941 |
|
|
2016
Q4 | $222K | Buy |
42,761
+16,531
| +63% | +$85.8K | ﹤0.01% | 3869 |
|
|
2016
Q3 | $661K | Buy |
26,230
+14,266
| +119% | +$360K | ﹤0.01% | 2984 |
|
|
2016
Q2 | $296K | Buy |
11,964
+2,339
| +24% | +$57.9K | ﹤0.01% | 3505 |
|
|
2016
Q1 | $279K | Buy |
9,625
+5,062
| +111% | +$147K | ﹤0.01% | 3548 |
|
|
2015
Q4 | $169K | Buy |
4,563
+2,184
| +92% | +$80.9K | ﹤0.01% | 3872 |
|
|
2015
Q3 | $116K | Buy |
2,379
+1,705
| +253% | +$83.1K | ﹤0.01% | 4108 |
|
|
2015
Q2 | $47K | Buy |
674
+549
| +439% | +$38.3K | ﹤0.01% | 4821 |
|
|
2015
Q1 | $4K | Sell |
125
-250
| -67% | -$8K | ﹤0.01% | 6296 |
|
|
2014
Q4 | $5K | Buy |
+375
| New | +$5K | ﹤0.01% | 6380 |
|